ClinicalTrials.Veeva

Menu

Comparison of Two New Generations Dressings in Intensive Care Unit (Advanced)

Grenoble Alpes University Hospital Center (CHU) logo

Grenoble Alpes University Hospital Center (CHU)

Status

Completed

Conditions

Catheter Related Complications

Study type

Observational

Funder types

Other

Identifiers

NCT01795391
ADVANCED

Details and patient eligibility

About

Intravascular devices in intensive care units are often associated to complications. The investigators estimate that 23.5% of catheters placed and used in intensive care are subject to at least one complication; the goal is to demonstrate the effectiveness of the new Tegaderm ™ IV Advanced dressings to achieve a decrease of 35% in the number of complications associated with intravascular catheters in intensive care.

Enrollment

685 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients over 18 years with a central venous catheter, an arterial catheter, a hemodialysis catheter, a Swan Ganz catheter or a peripheral catheter inserted in the ICU or within the 24 before their arrival at the ICU in another ICU setting.
  • Patients benefiting from the social security protection.

Exclusion criteria

  • Patients under 18 years of age,
  • Patients having known allergy or sensitivity to adhesive dressing materials

Trial design

685 participants in 2 patient groups

Tegaderm HP
Description:
Patients whose intravasculare devices dressings are made exclusevely with Tegaderm HP dressings.
Advanced
Description:
Patients whose intravasculare devices dressings are made exclusevely with Advanced dressings

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems